Literature DB >> 10202277

Prediction of response to 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with inoperable advanced gastric cancer by immunostaining of thymidine phosphorylase/platelet-derived endothelial cell growth factor.

W Koizumi1, K Saigenji, N Nakamaru, I Okayasu, M Kurihara.   

Abstract

BACKGROUND: No reliable method is available for predicting the response to chemotherapy in patients with gastric cancer. The anticancer drug 5'-deoxy-5-fluorouridine (5'-DFUR) is converted into 5-fluorouracil (5-FU) by thymidine phosphorylase (dThdPase). We studied the relation between the expression of dThdPase in tumor tissue and the response to treatment with 5'-DFUR to determine if this enzyme can be used to predict the response to chemotherapy. METHODS AND MATERIALS: We performed endoscopic biopsy and studied the expression of dThdPase by immunostaining with anti-dThdPase monoclonal antibody in 41 patients with inoperable advanced gastric carcinomas before they received multiple-drug chemotherapy, including 5'-DFUR. The relation between the expression of dThdPase and the response to chemotherapy was studied. We also studied the characteristics of positive cells against anti-dThdPase monoclonal antibody.
RESULTS: The response rate among patients whose tumors were positive for dThdPase expression (56.8%, 21/37) was higher than that among patients whose tumors were negative for dThdPase expression (0%, 0/4; p = 0.048). Spindle-shaped cells darkly expressing dThdPase were sporadically seen surrounding cancer nests in some patients. Multiple-antibody immunostaining suggested that these spindle-shaped cells were perivascular mesenchymal cells. The response rate was 82.4% (14/17) among patients with spindle-shaped cells strongly positive for dThdPase, as compared with 29.2% (7/24) among those with spindle-shaped cells weakly positive or negative for dThdPase (p = 0.00131). The expression of spindle-shaped cells darkly stained with dThdPase was the factor most strongly related to the response to chemotherapy (odds ratio = 35.513, p = 0.0027).
CONCLUSIONS: The expression of dThdPase in stromal spindle-shaped cells may be a useful index in predicting the response to 5'-DFUR in patients with gastric cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202277     DOI: 10.1159/000011968

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  12 in total

1.  Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes.

Authors:  In Sil Choi; Hye Seung Lee; Keun-Wook Lee; Haeryoung Kim; Ki Hwan Kim; Yu Jung Kim; Jee Hyun Kim; Woo Ho Kim; Jong Seok Lee
Journal:  Med Oncol       Date:  2010-06-09       Impact factor: 3.064

2.  Fluoropyrimidine plus cisplatin for patients with advanced or recurrent gastric cancer with peritoneal metastasis.

Authors:  Kohei Shitara; Ayako Mizota; Keitaro Matsuo; Yozo Sato; Chihiro Kondo; Daisuke Takahari; Takashi Ura; Masahiro Tajika; Kei Muro
Journal:  Gastric Cancer       Date:  2012-02-24       Impact factor: 7.370

3.  A retrospective comparison of S-1 plus cisplatin and capecitabine plus cisplatin for patients with advanced or recurrent gastric cancer.

Authors:  Kohei Shitara; Akira Sawaki; Keitaro Matsuo; Chihiro Kondo; Daisuke Takahari; Takashi Ura; Masahiro Tajika; Yasumasa Niwa; Kei Muro
Journal:  Int J Clin Oncol       Date:  2012-05-03       Impact factor: 3.402

Review 4.  Prediction of clinical outcome of fluoropyrimidine-based chemotherapy for gastric cancer patients, in terms of the 5-fluorouracil metabolic pathway.

Authors:  Wataru Ichikawa
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

Review 5.  Capecitabine.

Authors:  D R Budman
Journal:  Invest New Drugs       Date:  2000-11       Impact factor: 3.850

6.  Effects of smoking and alcohol consumption on 5-fluorouracil-related metabolic enzymes in oral squamous cell carcinoma.

Authors:  Tomomi Yamashita; Keizo Kato; Nguyen Khanh Long; Hiroki Makita; Kazuhiro Yonemoto; Kazuki Iida; Naritaka Tamaoki; Daijiro Hatakeyama; Toshiyuki Shibata
Journal:  Mol Clin Oncol       Date:  2014-03-07

7.  Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.

Authors:  Masanori Terashima; Hisataka Fujiwara; Akinori Takagane; Kaoru Abe; Takashi Irinoda; Tsutomu Nakaya; Hitoshi Yonezawa; Kenichi Oyama; Kazuyoshi Saito; Norio Kanzaki; Satoshi Ohtani; Tsuyoshi Nemoto; Yutaka Hoshino; Michihiko Kogure; Mitsukazu Gotoh
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

8.  Apoptosis induced by preoperative oral 5'-DFUR administration in gastric adenocarcinoma and its mechanism of action.

Authors:  Wen-He Zhao; Shi-Fu Wang; Wei Ding; Jian-Ming Sheng; Zhi-Min Ma; Li-Song Teng; Min Wang; Fu-Sheng Wu; Bing Luo
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

9.  Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancer.

Authors:  Hiroshi Makino; Hiroyuki Uetake; Kathleen Danenberg; Peter V Danenberg; Kenichi Sugihara
Journal:  BMC Cancer       Date:  2008-07-25       Impact factor: 4.430

10.  The expression of thymidine phosphorylase in cancer-infiltrating inflammatory cells in stomach cancer.

Authors:  Joung Soon Jang; Won Sup Lee; Jong Seok Lee; Hwal Woong Kim; Gyung Hyuck Ko; Woo Song Ha
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.